These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 904803)

  • 1. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy for advanced endometrial adenocarcinoma.
    Deppe G; Bruckner HW; Cohen CJ
    Int J Gynaecol Obstet; 1980; 18(3):168-9. PubMed ID: 6109646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
    Piver MS; Lele S; Barlow JJ
    Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemo-(hormonal)-therapy of advanced ovarian neoplasms in FIGO stages III and IV. Prospective SAKK-study 20/71].
    Senn HJ; Lei D; Castaño-Almendral A; Brunner KW; Martz G; Obrecht P; Melchert F; Rhomberg W
    Schweiz Med Wochenschr; 1980 Aug; 110(33):1202-8. PubMed ID: 7423163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medroxyprogesterone and endometrial adenocarcinoma].
    Serment H; Spitalier JM; Ayme Y; Degiovanni E; Bardin JP
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):93-7. PubMed ID: 5453572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progestins in combined treatment of endometrial cancer].
    Voznyĭ EK; Titova VA
    Sov Med; 1990; (9):102-7. PubMed ID: 2148437
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
    Bonte J; Drochmans A; Ide P
    Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
    Horger EO; Williamson HO; Hester LL
    J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
    Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
    Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
    Bonte J; Decoster JM; Ide P
    Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with progestational agents in the advanced phase of carcinoma of the endometrium. Study of 137 patients treated at the 1st division of obstetrics and gynecology of the San Camillo De Lellis Hospital in Rome].
    Rendina GM; Donadio C
    Minerva Ginecol; 1975 Dec; 27(12):1026-30. PubMed ID: 778677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
    Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.